BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32027096)

  • 1. Genetic association analysis identifies a role for ANO5 in prostate cancer progression.
    Yu CC; Chen LC; Huang CY; Lin VC; Lu TL; Lee CH; Huang SP; Bao BY
    Cancer Med; 2020 Apr; 9(7):2372-2378. PubMed ID: 32027096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
    Marx A; Koopmann L; Höflmayer D; Büscheck F; Hube-Magg C; Steurer S; Eichenauer T; Clauditz TS; Wilczak W; Simon R; Sauter G; Izbicki JR; Huland H; Heinzer H; Graefen M; Haese A; Schlomm T; Bernreuther C; Lebok P; Bonk S
    Cancer Biol Med; 2021 Feb; 18(1):245-255. PubMed ID: 33628598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer.
    Fukami T; Shiozaki A; Kosuga T; Kudou M; Shimizu H; Ohashi T; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Morinaga Y; Konishi E; Otsuji E
    World J Gastroenterol; 2022 Aug; 28(32):4649-4667. PubMed ID: 36157935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy.
    Yu CC; Chen LC; Lin VC; Huang CY; Cheng WC; Hsieh AR; Chang TY; Lu TL; Lee CH; Huang SP; Bao BY
    Cancer Med; 2019 Jun; 8(6):2777-2783. PubMed ID: 30993852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.
    Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Juang SH; Bao BY
    Sci Rep; 2015 Feb; 5():8556. PubMed ID: 25707771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.
    Oh JJ; Park S; Lee SE; Hong SK; Lee S; Lee HM; Lee JK; Ho JN; Yoon S; Byun SS
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1493-501. PubMed ID: 25764380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.
    Gu CY; Qin XJ; Qu YY; Zhu Y; Wan FN; Zhang GM; Sun LJ; Zhu Y; Ye DW
    Medicine (Baltimore); 2016 Jul; 95(27):e4066. PubMed ID: 27399092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.
    Lin VC; Huang SP; Huang CY; Yu CC; Yin HL; Huang TY; Lee CH; Lu TL; Bao BY
    Int J Med Sci; 2017; 14(12):1301-1306. PubMed ID: 29104488
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells.
    Laursen EB; Fredsøe J; Schmidt L; Strand SH; Kristensen H; Rasmussen AKI; Daugaard TF; Mouritzen P; Høyer S; Kristensen G; Stroomberg HV; Brasso K; Røder MA; Borre M; Sørensen KD
    Am J Pathol; 2019 Dec; 189(12):2377-2388. PubMed ID: 31539518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer.
    Chen CS; Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Bao BY
    Int J Med Sci; 2015; 12(3):243-7. PubMed ID: 25678841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANO7 is associated with aggressive prostate cancer.
    Kaikkonen E; Rantapero T; Zhang Q; Taimen P; Laitinen V; Kallajoki M; Jambulingam D; Ettala O; Knaapila J; Boström PJ; Wahlström G; Sipeky C; Pursiheimo JP; Tammela T; Kellokumpu-Lehtinen PL; ; Fey V; Maehle L; Wiklund F; Wei GH; Schleutker J
    Int J Cancer; 2018 Nov; 143(10):2479-2487. PubMed ID: 30157291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.
    Benko G; Spajić B; Krušlin B; Tomas D
    Urol Oncol; 2013 May; 31(4):468-74. PubMed ID: 21514185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
    Horning AM; Awe JA; Wang CM; Liu J; Lai Z; Wang VY; Jadhav RR; Louie AD; Lin CL; Kroczak T; Chen Y; Jin VX; Abboud-Werner SL; Leach RJ; Hernandez J; Thompson IM; Saranchuk J; Drachenberg D; Chen CL; Mai S; Huang TH
    Prostate; 2015 Nov; 75(15):1790-801. PubMed ID: 26332453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.
    Lee CH; Pao JB; Lu TL; Lee HZ; Lee YC; Liu CC; Huang CY; Lin VC; Yu CC; Yin HL; Huang SP; Bao BY
    Int J Med Sci; 2016; 13(9):696-700. PubMed ID: 27647999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anoctamin5 regulates cell migration and invasion in thyroid cancer.
    Chang Z; Cai C; Han D; Gao Y; Li Q; Feng L; Zhang W; Zheng J; Jin J; Zhang H; Wei Q
    Int J Oncol; 2017 Oct; 51(4):1311-1319. PubMed ID: 28902351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
    Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
    Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
    Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
    BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
    Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.